Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
C4 glomerulopathy screening
Introduction
Overview
Overview
There is insufficient information to recommend routine screening for C4 glomerulopathy.
Screening
Screening
There is insufficient evidence to recommend routine screening for C4 glomerulopathy. Quantifying CD46 expression on peripheral blood mononuclear cells for mutations and genes that encrypt complement factors include[1][2]:
- CFH
- CFI
- CD46 (encoding CD46)
- CFHR1, CFHR2, CFHR3, CFHR4, and CFHR5
- Genes that encode complement activators
- CFB
- C3
References
References
- ↑ Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G; et al. (2017). “C4 Nephritic Factors in C3 Glomerulopathy: A Case Series”. Am J Kidney Dis. 70 (6): 834–843. doi:10.1053/j.ajkd.2017.07.004. PMC 5701858. PMID 28838767.
- ↑ Bu F, Borsa NG, Jones MB, Takanami E, Nishimura C, Hauer JJ; et al. (2016). “High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies”. J Am Soc Nephrol. 27 (4): 1245–53. doi:10.1681/ASN.2015040385. PMC 4814193. PMID 26283675.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]